Trial intelligence / Profile preview

LoGo: Tailoring Gonal-f in Chronic Anovulation

NCT01871532Phase 4Terminated

Sponsor
Merck KGaA
Start
Jul 2013
Primary completion
Mar 2014
Modality
Recombinant Proteins and Enzymes
Countries
2
01

Overview

A Phase 4 trial of follitropin alfa in infertility, sponsored by Merck KGaA. Started Jul 2013; status: terminated.

02

Drugs

follitropin alfa
03

Conditions

infertility

Beyond the preview

Go deeper on NCT01871532.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01871532.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call